Table IV.
Comparison of ALB content prior to and following treatment between the short- and long-course groups.
| ALB content (g/l) | ALB recovered to normal (%) | |||
|---|---|---|---|---|
| Time point | Short-course treatment group | Long-course treatment group | Short-course treatment group | Long-course treatment group |
| Prior to treatment | 20.8±7.1 | 20.9±6.3 | – | – |
| Following treatment | ||||
| 1 month | 27.7±6.8 | 26.5±6.8 | 5 (14.3) | 4 (11.4) |
| 3 months | 28.8±5.7 | 28.5±6.6 | 10 (28.6) | 9 (25.7) |
| 6 months | 32.7±7.4 | 31.3±7.3 | 13 (37.1) | 15 (42.9) |
| 12 months | 35.3±4.8 | 35.9±5.0 | 17 (48.6) | 18 (51.4) |
| 18 months | 32.4±5.3 | 37.0±5.7a | 16 (45.7) | 21 (60.0)a |
| 24 months | 32.2±4.8 | 38.6±5.3a | 12 (34.3) | 19 (54.3)a |
Data are presented as n, the mean ± standard deviation.
a
P<0.05 vs. the short-course treatment group. ALB, albumin.